Your Good Partner in Biology Research

  1. 首页
  2. 试剂盒
  3. 酶联免疫试剂盒
  4. Human Aggrecan core protein(AGC1) ELISA kit

Human Aggrecan core protein(AGC1) ELISA kit

  • 中文名称：
    人蛋白聚糖(AGC1)酶联免疫试剂盒
  • 货号：
    CSB-EL001440HU
  • 规格：
    96T/48T
  • 价格：
    ￥3600/￥2500
  • 其他：

产品详情

  • 产品描述：

    This Human AGC1 ELISA Kit was designed for the quantitative measurement of Human AGC1 protein in serum, plasma, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 0.156 ng/mL-10 ng/mL and the sensitivity is 0.039 ng/mL.

  • 别名：
    ACAN ELISA Kit; AGC1 ELISA Kit; CSPG1 ELISA Kit; MSK16 ELISA Kit; Aggrecan core protein ELISA Kit; Cartilage-specific proteoglycan core protein ELISA Kit; CSPCP ELISA Kit; Chondroitin sulfate proteoglycan core protein 1 ELISA Kit; Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2] ELISA Kit
  • 缩写：
    AGC1
  • Uniprot No.：
  • 种属：
    Homo sapiens (Human)
  • 样本类型：
    serum, plasma, tissue homogenates
  • 检测范围：
    0.156 ng/mL-10 ng/mL
  • 灵敏度：
    0.039 ng/mL
  • 反应时间：
    1-5h
  • 样本体积：
    50-100ul
  • 检测波长：
    450 nm
  • 研究领域：
    Signal Transduction
  • 测定原理：
    quantitative
  • 测定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 线性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human AGC1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    　 Sample Serum(n=4)
    1:5 Average % 89
    Range % 83-94
    1:10 Average % 100
    Range % 95-105
    1:20 Average % 107
    Range % 103-110
    1:40 Average % 89
    Range % 85-91
  • 回收率：
    The recovery of human AGC1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 105 100-110
    EDTA plasma (n=4) 88 83-95
  • 标准曲线：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected
    10 2.484 2.431 2.458 2.281
    5 2.068 2.104 2.086 1.909
    2.5 1.410 1.500 1.455 1.278
    1.25 0.783 0.798 0.791 0.614
    0.625 0.484 0.501 0.493 0.316
    0.312 0.342 0.335 0.339 0.162
    0.156 0.239 0.241 0.240 0.063
    0 0.178 0.176 0.177 　
  • 数据处理：
  • 货期：
    3-5 working days

产品评价

靶点详情

  • 功能：
    This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.
  • 基因功能参考文献：
    1. Reciprocal translocation t(10;15)(q22.3;q26.1) interrupting ACAN gene is associated with short stature. PMID: 29302920
    2. genetic association studies in pediatric population in Japan: Data suggest that mutations in ACAN (aggrecan), FGFR3 (fibroblast growth factor receptor-3), or GHRHR (growth- hormone-releasing-hormone receptor) are associated with idiopathic short stature in the population studied. PMID: 28768959
    3. In bicuspid aortic valve disease, there was a significant reduction of aggrecan expression in bicuspid aortic valve. PMID: 28986054
    4. Overexpression of miR-3150a-3p decreased ACAN expression in nucleus pulposus cells, whereas inhibition of miR-3150a-3p increased ACAN expression. In addition, ACAN expression was negatively correlated with intervertebral disc degeneration (IDD) grade. The reduction of ACAN expression induced by the upregulation of miR-3150a-3p might participate in the development of IDD. PMID: 29554650
    5. Our study demonstrated that altered levels of ADAMTS-1 and aggrecan may have a partial role in the etiopathogenesis of Polycystic ovary syndrome (PCOS), and ADAMTS-1 could be a predictive marker for implantation success in PCOS patients. PMID: 28417352
    6. ACAN mutation is a relative common cause of familial severe short stature PMID: 28396070
    7. Chondrogenic potential was higher and Wnt/beta-catenin signaling was more potently activated by a GSK-3beta inhibitor in the posterior than in the anterior part of the human infant sclera. PMID: 27336854
    8. single nucleotide variants of ACAN and their haplotypes are associated with the severity of lumbar disc herniation. PMID: 28742099
    9. Four of 29 small for gestational age children with advanced bone age had an ACAN gene mutation (13.8%). Mutations were related to additional characteristics: midface hypoplasia, joint problems, and broad great toes. PMID: 27710243
    10. SNVs of candidate genes in ACAN metabolic pathway are associated with severity of Lumbar disc degeneration and Modic changes in patients with chronic mechanical low back pain. PMID: 28081267
    11. Heterozygous aggrecan mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. PMID: 27870580
    12. deacetylation promotes SOX9 nuclear translocation and hence its ability to activate ACAN. PMID: 26910618
    13. Femoral and tibial cartilage show a different behaviour concerning expression values for the genes Col1A1, Col2A1 and Agg. PMID: 28302318
    14. The genotype and allele frequencies of the COL2A1 genetic polymorphisms (rs1793953 and rs2276454) and the Aggrecan VNTR polymorphisms differed significantly between the case group and the control group.the genotype and allele frequencies of the COL2A1 genes, rs1793953 and rs2276454, and Aggrecan VNTR significantly differed in terms of Pfirrmann grades III, IV, and V PMID: 27991836
    15. Decrease in mRNA expression of ACAN is associated with Osteoarthritis. PMID: 27428952
    16. Results showed an association between short alleles and lumbar disc herniation (LDH), corroborating the hypothesis that aggrecan with shorter repeat lengths can lead to a reduction in the physiological proteoglycan function of intervertebral disc hydration and, consequently, increased individual susceptibility to LDH. PMID: 28002585
    17. Citrullinated Proteoglycan Aggrecan is a new member of citrullinated proteins identified in human joints. PMID: 26943656
    18. Idiopathic short stature is due to novel heterozygous mutation of the aggrecan gene. PMID: 25741789
    19. Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing. PMID: 25715982
    20. ACAN positive perineuronal nets and glial cells were decreased in the amygdala of szhizophrenia and bipolar disorder patients compared to controls. PMID: 25603412
    21. An underlying interaction between aggrecan VNTR and obesity in symptomatic lumbar disc herniation. PMID: 25188217
    22. The results suggest that regions within ACAN is associated with ACL injury susceptibility and that genetic sequence variability within genes encoding proteoglycans may potentially modulate the ligament fibril properties. PMID: 24552666
    23. results suggested that genetic variants in ACAN and MET are associated with HM. Functional roles of ACAN and MET in the development of HM need to be further investigated PMID: 24766640
    24. Data show there was no significant difference in the aggrecan (ACAN) rs1516797 genotype or allele distributions between the carpal tunnel syndrome (CTS) and control groups. PMID: 25173489
    25. Heterozygous mutations in ACAN can cause a mild skeletal dysplasia, which presents clinically as short stature with advanced bone age. PMID: 24762113
    26. ROCKi decreased the association between ETS-1 and its binding sites on the MMP-3 promoter, whereas ROCKi promoted the interaction between SOX9 and the AGN promoter. PMID: 24111521
    27. SHOX2, like SHOX, regulates NPPB directly whilst activates ACAN via its cooperation with the SOX trio. PMID: 24421874
    28. microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN. PMID: 24063364
    29. significant increased risks were found among Asians with shorter alleles of Aggrecan PMID: 24296484
    30. PKCepsilon activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKCepsilon/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs PMID: 24312401
    31. The expression of growth differentiation factor 5 (GDF5) and aggrecan in 15 cases of salivary gland pleomorphic adenomas, was investigated. PMID: 24398992
    32. Data indicate link protein peptide (LPP) upregulates expression of aggrecan and collagen II at both mRNA and protein levels. PMID: 23370687
    33. the subsequent presentation of aggregan from ECM leads to CD4(+) T-cell activation and effector cell formation. PMID: 24032649
    34. ADAMTS-4_v1 is expressed as a protein in vivo in human osteoarthritis synovium, functions as an aggrecanase, and cleaves other proteoglycan substrates. PMID: 23897278
    35. The total mole fraction of unelongated xylose residues per aggrecan was significantly less (p = 0.03) after IL-1beta treatment compared to control cultures. PMID: 23237500
    36. aggrecan alleles with shorter VNTR length have a role in intervertebral disc degeneration, while VDR (TaqI, FokI, ApaI) gene polymorphisms do not [meta-analysis] PMID: 23209686
    37. The concentration of aggrecan, biglycan, and decorin was determined in six regions of the human supraspinatus tendon. PMID: 22329809
    38. The reduction in keratan sulfate levels and the strong correlation between chondroitin 6-sulfate and keratan sulfate levels indi-cates suppressed cartilage turnover after arthroscopic surgery. PMID: 22441960
    39. Identification of enhancer sequences involved in the regulation of expression of the human ACAN gene. PMID: 22820679
    40. Data suggest that matrix metalloproteinases are mainly involved in normal aggrecan turnover in extracellular matrix and may have less-active roles in aggrecan degradation during knee injury or osteoarthritis (where aggrecanase-1 has central role). PMID: 22670872
    41. In the CNS, aggrecan is expressed in a precise and tightly regulated manner both temporally and spatially. (Review) PMID: 22297263
    42. Increased expression of collagen II, aggrecan, and cartilage oligomeric matrix protein (COMP), were observed during differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes. PMID: 22241609
    43. Yiqi Huayu Bushen Recipe increased the expression of aggrecan, decreased the expression of type X collagen, and promoted cell proliferation in cells from degenerated human intervertebral discs. PMID: 22015197
    44. In Turkish population, short repeated alleles of the aggrecan gene are associated with increased disc degeneration and disc herniation. PMID: 21948754
    45. Data show that a molecular complex of fibronectin and aggrecan predicts response to lumbar ESI for radiculopathic back pain with HNP. PMID: 21224775
    46. in the human cerebral cortex, discrete, layer-specific PNNs are assembled through the participation of selected aggrecan isoforms that characterize defined subsets of cortical neurons PMID: 19220578
    47. The objective of the present study was to assess the immunolocalization of aggrecan in the annulus, and to assess molecular gene expression patterns in the annulus extracellular matrix. PMID: 21689646
    48. Carrying a copy of the aggrecan allele with 21 repeats may increase the risk of multiple disc degeneration in subjects less than 40 years of age. PMID: 20936487
    49. This study tests the hypothesis that disease severity is characterized by alterations in expression of cartilage-specific genes for aggrecan and collagen type II. PMID: 21655647
    50. Confocal immunostaining demonstrated colocalization of m-calpain and the aggrecan product within the lower hypertrophic chondrocytes and in limited region of the pericellular matrix. PMID: 21117903

    显示更多

    收起更多

  • 相关疾病：
    Spondyloepiphyseal dysplasia type Kimberley (SEDK); Spondyloepimetaphyseal dysplasia, aggrecan type (SEMDAG); Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans (SSOAOD)
  • 亚细胞定位：
    Secreted, extracellular space, extracellular matrix.
  • 蛋白家族：
    Aggrecan/versican proteoglycan family
  • 组织特异性：
    Restricted to cartilages.
  • 数据库链接：

    HGNC: 319

    OMIM: 155760

    KEGG: hsa:176

    UniGene: Hs.2159